Gregory Cairncross
Impact in
- Genetics top 0.1%
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 36
- Glioma Diagnosis and Treatment 36
-
- Ocular Oncology and Treatments 7
- Co-authors
- Normand LaperrièreRobert B. JenkinsJan C. BucknerLuís SouhamiMinesh P. MehtaDavid BrachmanEdward ShawKaren Fink
- Journals
- Journal of Clinical Oncology (9 papers)International Journal of Radiation Oncology*Biology*Physics (6 papers)Neuro-Oncology (5 papers)Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (3 papers)Investigational New Drugs (2 papers)
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
Gregory Cairncross
41 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Genetics 3.0k
- Cancer Research 679
- Pulmonary and Respiratory Medicine 1.4k
- Neurology 602
- Radiology, Nuclear Medicine and Imaging 678
Countries citing papers authored by Gregory Cairncross
This map shows the geographic impact of Gregory Cairncross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Cairncross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Cairncross more than expected).
Fields of papers citing papers by Gregory Cairncross
This network shows the impact of papers produced by Gregory Cairncross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Cairncross. The network helps show where Gregory Cairncross may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gregory Cairncross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2013 | 165 | |
| 4 | Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402 Hit paper breakdown → | 2012 | 757 |
| 5 | 2009 | 40 | |
| 6 | 2008 | 220 | |
| 7 | 2008 | 10 | |
| 8 | 2008 | 23 | |
| 9 | 2008 | 6 | |
| 10 | Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402 Hit paper breakdown → | 2006 | 508 |
| 11 | 2005 | 5 | |
| 12 | 2004 | 17 | |
| 13 | 2003 | 3 | |
| 14 | 2002 | 283 | |
| 15 | 2001 | 34 | |
| 16 | 2000 | 27 | |
| 17 | 1999 | 120 | |
| 18 | 1996 | 35 | |
| 19 | 1995 | 18 | |
| 20 | 1994 | 335 |
About Gregory Cairncross
Gregory Cairncross is a scholar working on Genetics, Ophthalmology, Structural Biology, Neurology and Pulmonary and Respiratory Medicine, having authored 41 papers that have together received 3.7k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (36 papers), Brain Metastases and Treatment (16 papers), Ocular Oncology and Treatments (7 papers), Histone Deacetylase Inhibitors Research (6 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Epigenetics and DNA Methylation (4 papers), Neuroblastoma Research and Treatments (4 papers) and Meningioma and schwannoma management (3 papers). The work is most often cited by research in Genetics (3.0k citations), Cancer Research (679 citations), Pulmonary and Respiratory Medicine (1.4k citations), Neurology (602 citations) and Radiology, Nuclear Medicine and Imaging (678 citations). Gregory Cairncross has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Normand Laperrière, Robert B. Jenkins, Jan C. Buckner, Luís Souhami, Minesh P. Mehta, David Brachman, Edward Shaw, Karen Fink, Lisa Zuraw and David Macdonald. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Neuro-Oncology, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.